Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285402122> ?p ?o ?g. }
- W4285402122 endingPage "128318" @default.
- W4285402122 startingPage "128318" @default.
- W4285402122 abstract "The mercaptopurine (MP) anticancer drug was investigated here regarding the tautomeric formations and complexation with an iron (Fe)-doped fullerene cage (FFC). The molecular structures were analyzed by performing quantum chemical calculations in three phases including gas (G), oil (O), and water (W). The values of partition coefficient (LogP) were calculated in this regard. Ten tautomers of MP; T1–T10, were found with the highest stability for one of thio-state tautomers; T2. Moreover, the existence of solvent media helped to make higher stable tautomeric structures in comparison with the gas phase. Next, the complexation of T2 with the FFC yielded three MP@FFC complexes approved by the approach of quantum theory of atoms in molecules (QTAIM). All energies and electronic features indicated the possibility of formation of MP@FFC complexes for approaching two roles of adsorption and sensor function. Finally, the idea of combination with FFC was a proposed way for approaching safer MP. • Complexation of mercaptopurine (MP) with an iron (Fe)-doped fullerene cage (FFC) was investigated. • The molecular structures were analyzed in three phases including gas (G), oil (O), and water (W). • The complexation of T2 with the FFC yielded three MP@FFC complexes. • The idea of combination with FFC was a proposed way for approaching safer MP." @default.
- W4285402122 created "2022-07-14" @default.
- W4285402122 creator A5003115532 @default.
- W4285402122 creator A5003692376 @default.
- W4285402122 creator A5028005160 @default.
- W4285402122 creator A5034144676 @default.
- W4285402122 creator A5038705569 @default.
- W4285402122 creator A5051719727 @default.
- W4285402122 creator A5054875117 @default.
- W4285402122 date "2022-10-01" @default.
- W4285402122 modified "2023-09-27" @default.
- W4285402122 title "Complexation of mercaptopurine anticancer drug with an iron-doped fullerene cage: DFT assessments of drug delivery approach" @default.
- W4285402122 cites W1552630347 @default.
- W4285402122 cites W1653050201 @default.
- W4285402122 cites W2016956375 @default.
- W4285402122 cites W2019142785 @default.
- W4285402122 cites W2031501074 @default.
- W4285402122 cites W2048246800 @default.
- W4285402122 cites W2050464998 @default.
- W4285402122 cites W2063639336 @default.
- W4285402122 cites W2067011309 @default.
- W4285402122 cites W2108463221 @default.
- W4285402122 cites W2125871030 @default.
- W4285402122 cites W2127674396 @default.
- W4285402122 cites W2130395310 @default.
- W4285402122 cites W2134607638 @default.
- W4285402122 cites W2333815018 @default.
- W4285402122 cites W2342397060 @default.
- W4285402122 cites W2414304948 @default.
- W4285402122 cites W2524877581 @default.
- W4285402122 cites W2534749128 @default.
- W4285402122 cites W2616293111 @default.
- W4285402122 cites W2770444495 @default.
- W4285402122 cites W2787566830 @default.
- W4285402122 cites W2801640587 @default.
- W4285402122 cites W2890167612 @default.
- W4285402122 cites W2892614181 @default.
- W4285402122 cites W2896124512 @default.
- W4285402122 cites W2898907150 @default.
- W4285402122 cites W2904897030 @default.
- W4285402122 cites W2921110755 @default.
- W4285402122 cites W2946329645 @default.
- W4285402122 cites W2965666205 @default.
- W4285402122 cites W2966386072 @default.
- W4285402122 cites W2972484478 @default.
- W4285402122 cites W2991225358 @default.
- W4285402122 cites W2992244067 @default.
- W4285402122 cites W3001012285 @default.
- W4285402122 cites W3006093794 @default.
- W4285402122 cites W3023359121 @default.
- W4285402122 cites W3030188442 @default.
- W4285402122 cites W3046654061 @default.
- W4285402122 cites W3047881241 @default.
- W4285402122 cites W3080941325 @default.
- W4285402122 cites W3096590397 @default.
- W4285402122 cites W3109110891 @default.
- W4285402122 cites W3112979034 @default.
- W4285402122 cites W3118504991 @default.
- W4285402122 cites W3139522468 @default.
- W4285402122 cites W3141730727 @default.
- W4285402122 cites W3153422001 @default.
- W4285402122 cites W3164520290 @default.
- W4285402122 cites W3164986159 @default.
- W4285402122 cites W3173373210 @default.
- W4285402122 cites W3182055317 @default.
- W4285402122 cites W3195664632 @default.
- W4285402122 cites W3200507576 @default.
- W4285402122 cites W3202658268 @default.
- W4285402122 cites W3204766889 @default.
- W4285402122 cites W3206601176 @default.
- W4285402122 cites W3207156561 @default.
- W4285402122 cites W3207175112 @default.
- W4285402122 cites W3208761629 @default.
- W4285402122 cites W3213300473 @default.
- W4285402122 cites W3215279910 @default.
- W4285402122 cites W3216302668 @default.
- W4285402122 cites W4200310268 @default.
- W4285402122 cites W4226019300 @default.
- W4285402122 cites W572193077 @default.
- W4285402122 cites W839149746 @default.
- W4285402122 doi "https://doi.org/10.1016/j.physleta.2022.128318" @default.
- W4285402122 hasPublicationYear "2022" @default.
- W4285402122 type Work @default.
- W4285402122 citedByCount "2" @default.
- W4285402122 countsByYear W42854021222022 @default.
- W4285402122 countsByYear W42854021222023 @default.
- W4285402122 crossrefType "journal-article" @default.
- W4285402122 hasAuthorship W4285402122A5003115532 @default.
- W4285402122 hasAuthorship W4285402122A5003692376 @default.
- W4285402122 hasAuthorship W4285402122A5028005160 @default.
- W4285402122 hasAuthorship W4285402122A5034144676 @default.
- W4285402122 hasAuthorship W4285402122A5038705569 @default.
- W4285402122 hasAuthorship W4285402122A5051719727 @default.
- W4285402122 hasAuthorship W4285402122A5054875117 @default.
- W4285402122 hasConcept C111233374 @default.
- W4285402122 hasConcept C147597530 @default.
- W4285402122 hasConcept C162862793 @default.
- W4285402122 hasConcept C178790620 @default.